Clinical Trials Insight: 700032110
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2008
At a glance
- Drugs RDEA 436 (Primary)
- Indications Cancer; Inflammation
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Pharmacokinetics
- Sponsors Ardea Biosciences
- 14 Nov 2008 Planned start date reported as the first quarter of 2009 by Ardea Biosciences.
- 07 Oct 2008 Planned start date reported as the fourth quarter of 2008 by Ardea Biosciences.
- 17 Apr 2008 The trial is expected to be initiated in the second half of 2008.